News
News
Outcome Capital Named Top Life Sciences Advisory and Strategic Investment Banking Solutions Provider for 2026
Outcome Capital has been named Life Sciences Review’s exclusive recipient of the “Top Life Sciences Advisory and Strategic Investment Banking Solutions 2026” award, recognizing its unique approach to helping life sciences companies move innovations from development to commercialization. The firm combines scientific, clinical, operational, and financial expertise to support emerging and growth-stage companies with fundraising, […]
Read MoreResources
Outcome Capital Life Science Pulse
Outcome Capital Life Science Market Pulse May 2026 Click to view our LifeSciences Pulse Newsletter
DownloadNews
The Contract Waterfall: Important Financial Tool in a Federal Government Contractor’s Toolset
The Contract Waterfall: Important Financial Tool in a Federal Government Contractor’s Toolset The contract waterfall plays an important role for both the buyer and the...
Read MoreNews
Outcome Capital Advises Forward Photonics in its Sale
Outcome Capital Advises Forward Photonics in its Sale April 24, 2020, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreNews
Outcome Capital Secures Growth Capital for Whisker Labs
Outcome Capital Secures Growth Capital for Whisker Labs November 26, 2019, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies...
Read MoreNews
Outcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science
Outcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science June 4, 2019, Boston, MA...
Read MoreNews
Outcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies
Outcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies May 29, 2019, Reston, VA Outcome Capital, an investment...
Read MoreNews
Outcome Capital Announces Meridian Bioscience Has Acquired GenePOC
Outcome Capital Announces Meridian Bioscience Has Acquired GenePOC May 1, 2019, BOSTON, MA –(BUSINESS WIRE)– Outcome Capital, a specialized investment banking firm that serves middle...
Read MoreNews
Federal Data Systems Has Received an Investment from McNally Capital
Federal Data Systems Has Received an Investment from McNally Capital August 30, 2018, Reston, VA Federal Data Systems, Inc (FedData) has received an investment from...
Read MoreNews
Outcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group
Outcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group June 18, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that...
Read MoreNews
BIO18: Pfizer’s Bourla on Volume vs. Value & a Little Dealmaking Advice from Outcome Capital
Partnerships and the move to value dominated the chatter at the BIO International Convention's 25th annual partnering meeting on Monday in the life science hub of Boston.
Read MoreNews
Outcome Capital Adds Veteran Government Services Investment Banker
June 1, 2018, Reston, VA & Boston, MA. Outcome Capital (outcomecapital.com), a 20-year-old investment banking boutique that serves the middle market in the technology and...
Read MoreNews
Outcome Capital Announces ATPCO Has Acquired Routehappy
Outcome Capital Announces ATPCO Has Acquired Routehappy February 26, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that serves middle market...
Read MoreNews
36th Annual JP Morgan Healthcare Conference
Outcome Capital looks forward to attending JP Morgan’s Annual Healthcare Conference in January 2018. If you are interested in meeting to discuss your...
Read MoreNews
Licensing Executives Society 2017 Annual Meeting
Plenary Session: Different Approaches VCs Take When Investing in Companies Tuesday, October 24th 2:30 PM – 3:30 PM Location: Grand Ballroom—Salons 1 & 2 (7th...
Read MoreNews
Slone Partners Networking Event
Building an Amazing Organization with the Strength of the Right Financial Partners Oded Ben-Joseph, PhD. from Outcome Capital is pleased to take part as...
Read MoreNews
Outcome Capital and Boston University’s BEST Program Partner to Give Scientists Real-Life Experience in the Life Science Sector
Outcome Capital and Boston University’s BEST Program Partner to Give Scientists Real-Life Experience in the Life Science Sector June 21, 2017, Boston, MA. Outcome Capital,...
Read MoreNews
UCB Pharma Acquires Beryllium Discovery
Outcome Capital Announces UCB Pharma Has Acquired Beryllium Discovery June 6, 2017, Boston, MA. Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreNews
Outcome Capital Congratulates ColonaryConcepts on Sale
Outcome Capital Congratulates ColonaryConcepts on Sale of Colon Preparation Business Unit to Sebela Pharmaceuticals June 1, 2017, Boston, MA. Outcome Capital (outcomecapital.wpengine.com), a highly specialized investment...
Read MoreNews
Outcome Capital Expands Biotech Practice With Hire of Dr. Ellen S. Baron
Dr. Baron’s Extensive Life Science Investment Experience and Deep Knowledge of Emerging Growth Pharma and Biotech Markets Will Bolster Outcome’s Client Service Offerings January 24,...
Read MoreNews
Active VCs vs. Zombies: Dysfunctional Boards That Mess With M&A
Investors want to know: Will Big Pharma go bargain hunting, do a little M&A? Will it lift my biotech portfolio out of the gutter? Multiple factors are always at work. At the most basic level, pharma still needs to acquire new products to stay afloat. Little biotechs who create things need to be acquired, or go public, to reward their investors. Those facts never change. But there’s another powerful, and dark, force creating havoc in many biotech boardrooms. People who have witnessed it don’t like to talk about it. When they do, it’s in hushed tones...
Read MoreNews
Outcome Capital and Sawyer Business School Partner to Give Students Real-Life Experience in the Life Sciences and Technology Sectors
December 07, 2016, Boston, MA. Outcome Capital, LLC today announced a collaboration with Suffolk University’s Sawyer Business School aimed at providing graduate-level students with real-world...
Read MoreContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
